메뉴 건너뛰기
American Journal of Health-System Pharmacy
Volumn 65, Issue 24, 2008, Pages 2328-2329
Bias in AJHP supplements [1]
Author keywords

[No Author keywords available]
Indexed keywords

ENOXAPARIN; FONDAPARINUX; HEPARIN;
EID: 57649115438     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080453     Document Type: Letter
Times cited : (1)
References (8)
  • 1
    • 34848927228 scopus 로고    scopus 로고
    • Kruse MW, Lee JJ. Questionable conclusions about epoetin alfa. Am J Health-Syst Pharm. 2007; 64:1789-90. Letter. [Erratum, Am J Health-Syst Pharm. 2008; 65:286.]
    • Kruse MW, Lee JJ. Questionable conclusions about epoetin alfa. Am J Health-Syst Pharm. 2007; 64:1789-90. Letter. [Erratum, Am J Health-Syst Pharm. 2008; 65:286.]
  • 2
    • 49549124264 scopus 로고    scopus 로고
    • Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome
    • Dobesh PP, Phillips KW, Haines ST. Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome. Am J Health-Syst Pharm. 2008; 65(suppl 7):S22-28.
    • (2008) Am J Health-Syst Pharm , vol.65 , Issue.SUPPL. 7
    • Dobesh, P.P.1    Phillips, K.W.2    Haines, S.T.3
  • 3
    • 33645498094 scopus 로고    scopus 로고
    • Comparison of fondaparinux and enoxaparin in acute coronary syndromes
    • The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators
    • The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, Yusuf S, Mehta SR et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006; 354:1464-76.
    • (2006) N Engl J Med , vol.354 , pp. 1464-1476
    • Yusuf, S.1    Mehta, S.R.2
  • 4
    • 57649124758 scopus 로고    scopus 로고
    • Theheart.org. Heartwire. Hughes, S. OASIS-5/Michelangelo: Dramatically reduced bleeding favors fondaparinux over enoxaparin in ACS. www.theheart.org/article/554453.do (accessed 2008 Aug 12).
    • Theheart.org. Heartwire. Hughes, S. OASIS-5/Michelangelo: Dramatically reduced bleeding favors fondaparinux over enoxaparin in ACS. www.theheart.org/article/554453.do (accessed 2008 Aug 12).
  • 5
    • 35348987492 scopus 로고    scopus 로고
    • Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
    • Mehta SR, Granger CB, Eikelboom JW et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol. 2007; 50:1742-51.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 1742-1751
    • Mehta, S.R.1    Granger, C.B.2    Eikelboom, J.W.3
  • 6
    • 34548590321 scopus 로고    scopus 로고
    • Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes
    • Fox KA, Bassand JP, Mehta SR et al. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med. 2007; 147:304-10.
    • (2007) Ann Intern Med , vol.147 , pp. 304-310
    • Fox, K.A.1    Bassand, J.P.2    Mehta, S.R.3
  • 7
    • 0141594931 scopus 로고    scopus 로고
    • Bivalirudin provides increasing benefit with decreasing renal function: A meta-analysis of randomized trials
    • Chew DP, Bhatt DL, Kimball W et al. Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. Am J Cardiol. 2003; 92:919-23.
    • (2003) Am J Cardiol , vol.92 , pp. 919-923
    • Chew, D.P.1    Bhatt, D.L.2    Kimball, W.3
  • 8
    • 57649125594 scopus 로고    scopus 로고
    • American Journal of Health-System Pharmacy, accessed 2008 Aug 12
    • American Journal of Health-System Pharmacy. AJHP supplements. www.ajhp.org/misc/supplements.dtl (accessed 2008 Aug 12).
    • AJHP supplements

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.